These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 25316

  • 1. Use of propoxyphene napsylate for detoxification of a child with morphine sulfate tolerance and physical dependence.
    Udkow G, Weintraub M.
    J Pediatr; 1978 May; 92(5):829-31. PubMed ID: 25316
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic usefulness of propoxyphene napsylate in narcotic addiction.
    Jasinski DR, Pevnick JS, Clark SC, Griffith JD.
    Arch Gen Psychiatry; 1977 Feb; 34(2):227-33. PubMed ID: 14602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.
    Wang RI, Kochar C, Hasegawa AT, Roh BL.
    NIDA Res Monogr; 1982 Apr; 41():253-60. PubMed ID: 6126814
    [Abstract] [Full Text] [Related]

  • 7. Propoxyphene napsylate.
    Lasagna L.
    Ann Intern Med; 1976 Nov; 85(5):619-21. PubMed ID: 10824
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Propoxyphene napsylate detoxification.
    Schmalstieg WJ, Hayden JW, Comstock EG.
    Tex Med; 1975 Apr; 71(4):70-6. PubMed ID: 1135758
    [No Abstract] [Full Text] [Related]

  • 10. Propoxyphene form maintenance treatment of narcotic addiction.
    Woody GE, Mintz J, Tennant F, O'Brien CP, McLellan AT, Marcovici M.
    Arch Gen Psychiatry; 1981 Aug; 38(8):898-900. PubMed ID: 6114721
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Propoxyphene napsylate maintenance treatment for narcotic dependence: a non-methadone model.
    Tennant FS, Rawson RA.
    Drug Alcohol Depend; 1981 Aug; 8(1):79-83. PubMed ID: 6117456
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Subacute painful myopathy from chronic propoxyphene napsylate abuse.
    Dalakas MC.
    JAMA; 1986 Apr 04; 255(13):1709. PubMed ID: 2869152
    [No Abstract] [Full Text] [Related]

  • 16. Lack of toxicity of high dose propoxyphene napsylate when used for maintenance treatment of addiction.
    Woody GE, McLellan AT, O'Brien CP, Tennant FS, Mintz J.
    Clin Toxicol; 1980 Jun 04; 16(4):473-8. PubMed ID: 6105935
    [No Abstract] [Full Text] [Related]

  • 17. Propoxyphene napsylate compared to methadone for opiate dependence.
    Wang RI, Kochar C, Hasegawa AT, Roh BL.
    Psychopharmacology (Berl); 1981 Jun 04; 75(4):335-8. PubMed ID: 6122232
    [Abstract] [Full Text] [Related]

  • 18. Propoxyphene napsylate maintenance treatment of narcotic dependence: use of a non-methadone model.
    Tennant FS, Rawson RA.
    NIDA Res Monogr; 1982 Apr 04; 41():246-52. PubMed ID: 6126813
    [Abstract] [Full Text] [Related]

  • 19. Serum propoxyphene concentrations in a cohort of opiate addicts on long-term propoxyphene maintenance therapy. Evidence for drug tolerance in humans.
    Hartman B, Miyada DS, Pirkle H, Sedgwick P, Cravey RH, Tennant FS, Wolen RL.
    J Anal Toxicol; 1988 Apr 04; 12(1):25-9. PubMed ID: 3352239
    [Abstract] [Full Text] [Related]

  • 20. Propoxyphene hydrochloride. A critical review.
    Miller RR, Feingold A, Paxinos J.
    JAMA; 1970 Aug 10; 213(6):996-1006. PubMed ID: 4914209
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.